Work

The Bcl-2 inhibitor ABT-263 enhances the response of multiple chemotherapeutic regimens in hematologic tumors in vivo

Year: 2010

Type: article

Source: Cancer Chemotherapy and Pharmacology

DOI: 10.1007/s00280-009-1232-1

Authors: Scott Ackler, Michael J. Mitten, Kelly Foster, Anatol Oleksijew, Marion Refici, Stephen K. Tahir, Yu Xiao, Christin Tse, David J. Frost, Stephen W. Fesik, Saul H. Rosenberg, Steven W. Elmore, Alexander R. Shoemaker

Institutions: Abbott (United States), Vanderbilt University, Vanderbilt University Medical Center

Language: English

Topic: Cell death mechanisms and regulation

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2010571756

FWCI: 4.976

Cites: 45

Cited by: 124

Related to: 10